e-learning
resources
Virtual 2020
Wednesday, 09.09.2020
Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Differential effects of pirfenidone and nintedanib on mouse alveolar epithelial organoids
M. Woest (Groningen, Netherlands), V. Verschut (Groningen, Netherlands), R. Gosens (Groningen, Netherlands), L. Kistemaker (Groningen, Netherlands)
Source:
Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Session:
Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Session type:
Oral Presentation
Number:
5030
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Woest (Groningen, Netherlands), V. Verschut (Groningen, Netherlands), R. Gosens (Groningen, Netherlands), L. Kistemaker (Groningen, Netherlands). Differential effects of pirfenidone and nintedanib on mouse alveolar epithelial organoids. 5030
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
Surfactant protein expression at various COPD Gold stages
Dexamethasone inhibits secretory and cytosolic phospholipases A2 in alveolar macrophages in acute lung injury
Related content which might interest you:
HDAC2-independent anti-inflammatory effects of budesonide in human lung fibroblasts
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Anti-fibrotic effect of Atorvastatin on the lung fibroblasts and myofibroblasts
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
Modulatory effects of immunosuppressives on IL-8 and GM-CSF expression in bronchial and alveolar epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 854s
Year: 2006
The cell-protective effect of klotho protein on alveolar epithelial cells
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009
The antiinflammatory effect of statins on human bronchial epithelial cells
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
The antiinflammatory effect of statins on human bronchial epithelial cells
Source: Annual Congress 2008 - Airway cell biology
Year: 2008
PP205 – Effect of mTOR inhibition in a 3D in vitro model of alveolar epithelium and epithelial regeneration
Source: ERS Lung Science Conference 2021
Year: 2021
PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: ERS Lung Science Conference 2021
Year: 2021
Kaempferol-induced HO-1 expression attenuated inflammation in human pulmonary alveolar epithelial cells
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017
Protective effect of MAPK inhibitors and budesonide against apoptosis induced by TGF-β in primary cultures of human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 394s
Year: 2003
Different effects of mesenchymal stem cells on elastase-induced pulmonary emphysema and macrophages activity in rats
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Alveolar epithelial cell-specific gene expression in the mouse lung
in vivo
Source: Eur Respir J 2005; 26: Suppl. 49, 231s
Year: 2005
Inflammatory and antioxidant effects of inhaled nanoparticles on human primary bronchial epithelial cells
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019
Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
Paraquat induced damage in rat lung epithelial cells and alveolar macrophages
Source: Eur Respir J 2001; 18: Suppl. 33, 79s
Year: 2001
Modulation of NOS2 expression in co-cultures of human alveolar epithelial cells type II and alveolar macrophages
Source: Eur Respir J 2001; 18: Suppl. 33, 161s
Year: 2001
Role of p53 in murine macrophages and alveolar epithelial cells response to nanoparticles
Source: Annual Congress 2011 - Environmental exposure and disease mechanisms
Year: 2011
Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 39s
Year: 2003
Primary human airway epithelial cells inhibit proliferation of lung fibroblasts
via
transforming growth factor-β
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007
Proteoglycan production in cultured human lung fibroblasts is synergistcally inhibited by combination of budesonide and formoterol
Source: Eur Respir J 2003; 22: Suppl. 45, 286s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept